Monthly
US$200
Billed every month
Sign in to subscribeAs of 16 November 2026, for Fosfomycin Sodium For Injection, 16 applications are listed as under review at China's CDE; 2 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 2 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 3 applicationsNo longer listed under review: 3 applicationsNotification delivery: 2 applications
Current coverage may be incomplete
Free: up to 3 drugs, Monday digest. Sign in with Google or an email code. No card needed.
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Loaded records: 2 holders; 1 in the quality-and-efficacy consistency-evaluation category, and 1 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized | Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H20263060 | 2026/01/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized | Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H20263059 | 2026/01/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Xiamen Bao Rui Pharma Co., Ltd. romanized | Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H20247323 | 2024/12/20 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Xiamen Bao Rui Pharma Co., Ltd. romanized | Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H44023267 | 2024/12/20 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Xiamen Bao Rui Pharma Co., Ltd. romanized | Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H20247324 | 2024/12/20 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
Loaded records: 40 distinct approval numbers and 15 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Xiamen Bao Rui Pharma Co., Ltd. romanized | 国药准字H44023267 | See source | Category A | XJ01XXL096B001010100322 | NHSA |
| Shanghai Shang Yao Xin Ya Pharma Co., Ltd. romanized | 国药准字H19993732 | See source | Category A | XJ01XXL096B001010100796 | NHSA |
| Dong Bei Pharmaceutical Group Shenyang Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H19993975 | 1.0g | Category A | XJ01XXL096B001010101162 | NHSA |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | 国药准字H20057067 | See source | Category A | XJ01XXL096B001010102690 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20053393 | 1g | Category A | XJ01XXL096B001010102777 | NHSA |
| Hubei Min Kang Pharmaceutical Co., Ltd. romanized | 国药准字H19993360 | 1g | Category A | XJ01XXL096B001010102946 | NHSA |
| Shanxi Shuang Yan Pharma Co., Ltd. romanized | 国药准字H19993840 | 1.0g | Category A | XJ01XXL096B001010102954 | NHSA |
| Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | 国药准字H19999109 | See source | Category A | XJ01XXL096B001010103705 | NHSA |
| Ha Yao Group Pharmaceutical Factory romanized | 国药准字H20043046 | See source | Category A | XJ01XXL096B001010103712 | NHSA |
| Hainan Wei Kang Pharmaceutical (Qian Shan) Co., Ltd. romanized | 国药准字H20044787 | See source | Category A | XJ01XXL096B001010104384 | NHSA |
| Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H43020769 | See source | Category A | XJ01XXL096B001010105006 | NHSA |
| Haikou Qi Li Pharmaceutical Co., Ltd. romanized | 国药准字H20053403 | See source | Category A | XJ01XXL096B001010105755 | NHSA |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | 国药准字H20045995 | See source | Category A | XJ01XXL096B001010105821 | NHSA |
| Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized | 国药准字H20263060 | See source | Category A | XJ01XXL096B001010184971 | NHSA |
| Xiamen Bao Rui Pharma Co., Ltd. romanized | 国药准字H44023267 | See source | Category A | XJ01XXL096B001010200322 | NHSA |
| Dong Bei Pharmaceutical Group Shenyang Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H19993975 | 1.0g | Category A | XJ01XXL096B001010201162 | NHSA |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | 国药准字H20057067 | See source | Category A | XJ01XXL096B001010202690 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20053393 | 1g | Category A | XJ01XXL096B001010202777 | NHSA |
| Shanxi Shuang Yan Pharma Co., Ltd. romanized | 国药准字H19993840 | 1.0g | Category A | XJ01XXL096B001010202954 | NHSA |
| Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | 国药准字H19999109 | See source | Category A | XJ01XXL096B001010203705 | NHSA |
| Hainan Wei Kang Pharmaceutical (Qian Shan) Co., Ltd. romanized | 国药准字H20044787 | See source | Category A | XJ01XXL096B001010204384 | NHSA |
| Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H43020769 | See source | Category A | XJ01XXL096B001010205006 | NHSA |
| Haikou Qi Li Pharmaceutical Co., Ltd. romanized | 国药准字H20053403 | See source | Category A | XJ01XXL096B001010205755 | NHSA |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | 国药准字H20045995 | See source | Category A | XJ01XXL096B001010205821 | NHSA |
| Hubei Min Kang Pharmaceutical Co., Ltd. romanized | 国药准字H19993360 | 1g | Category A | XJ01XXL096B001010302946 | NHSA |
| Xiamen Bao Rui Pharma Co., Ltd. romanized | 国药准字H44023267 | See source | Category A | XJ01XXL096B001020100322 | NHSA |
| Shanghai Shang Yao Xin Ya Pharma Co., Ltd. romanized | 国药准字H19999518 | See source | Category A | XJ01XXL096B001020100796 | NHSA |
| Dong Bei Pharmaceutical Group Shenyang Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H19993974 | 2.0g | Category A | XJ01XXL096B001020101162 | NHSA |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | 国药准字H20058179 | See source | Category A | XJ01XXL096B001020102690 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20053394 | 2g | Category A | XJ01XXL096B001020102777 | NHSA |
| Hubei Min Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20083571 | 2.0g | Category A | XJ01XXL096B001020102946 | NHSA |
| Shanxi Shuang Yan Pharma Co., Ltd. romanized | 国药准字H19993841 | 2.0g | Category A | XJ01XXL096B001020102954 | NHSA |
| Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | 国药准字H20013341 | See source | Category A | XJ01XXL096B001020103705 | NHSA |
| Ha Yao Group Pharmaceutical Factory romanized | 国药准字H20043047 | See source | Category A | XJ01XXL096B001020103712 | NHSA |
| Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H43020770 | See source | Category A | XJ01XXL096B001020105006 | NHSA |
| Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized | 国药准字H20263059 | See source | Category A | XJ01XXL096B001020184971 | NHSA |
| Dong Bei Pharmaceutical Group Shenyang Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H19993974 | 2.0g | Category A | XJ01XXL096B001020201162 | NHSA |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | 国药准字H20058179 | See source | Category A | XJ01XXL096B001020202690 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20053394 | 2g | Category A | XJ01XXL096B001020202777 | NHSA |
| Hubei Min Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20083571 | 2.0g | Category A | XJ01XXL096B001020202946 | NHSA |
| Shanxi Shuang Yan Pharma Co., Ltd. romanized | 国药准字H19993841 | 2.0g | Category A | XJ01XXL096B001020202954 | NHSA |
| Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | 国药准字H20013341 | See source | Category A | XJ01XXL096B001020203705 | NHSA |
| Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H43020770 | See source | Category A | XJ01XXL096B001020205006 | NHSA |
| Xiamen Bao Rui Pharma Co., Ltd. romanized | 国药准字H44023267 | See source | Category A | XJ01XXL096B001030100322 | NHSA |
| Shanghai Shang Yao Xin Ya Pharma Co., Ltd. romanized | 国药准字H20023346 | See source | Category A | XJ01XXL096B001030100796 | NHSA |
| Dong Bei Pharmaceutical Group Shenyang Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H19999111 | 4.0g | Category A | XJ01XXL096B001030101162 | NHSA |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | 国药准字H20057068 | See source | Category A | XJ01XXL096B001030102690 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20053395 | 4g | Category A | XJ01XXL096B001030102777 | NHSA |
| Hubei Min Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20033427 | 4.0g | Category A | XJ01XXL096B001030102946 | NHSA |
| Shanxi Shuang Yan Pharma Co., Ltd. romanized | 国药准字H20053765 | 3.0g | Category A | XJ01XXL096B001030102954 | NHSA |
| Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | 国药准字H20033224 | See source | Category A | XJ01XXL096B001030103705 | NHSA |
| Ha Yao Group Pharmaceutical Factory romanized | 国药准字H20043048 | See source | Category A | XJ01XXL096B001030103712 | NHSA |
| Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H43020771 | See source | Category A | XJ01XXL096B001030105006 | NHSA |
| Shanghai Shang Yao Xin Ya Pharma Co., Ltd. romanized | 国药准字H20023346 | See source | Category A | XJ01XXL096B001030200796 | NHSA |
| Dong Bei Pharmaceutical Group Shenyang Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H19999111 | 4.0g | Category A | XJ01XXL096B001030201162 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20053395 | 4g | Category A | XJ01XXL096B001030202777 | NHSA |
| Hubei Min Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20033427 | 4.0g | Category A | XJ01XXL096B001030202946 | NHSA |
| Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | 国药准字H20033224 | See source | Category A | XJ01XXL096B001030203705 | NHSA |
| Ha Yao Group Pharmaceutical Factory romanized | 国药准字H20043048 | See source | Category A | XJ01XXL096B001030203712 | NHSA |
| Xiamen Bao Rui Pharma Co., Ltd. romanized | 国药准字H20247324 | See source | Category A | XJ01XXL096B001040100322 | NHSA |
| Shanghai Shang Yao Xin Ya Pharma Co., Ltd. romanized | 国药准字H20023345 | See source | Category A | XJ01XXL096B001040100796 | NHSA |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | 国药准字H20057068 | See source | Category A | XJ01XXL096B001040102690 | NHSA |
| Shanxi Shuang Yan Pharma Co., Ltd. romanized | 国药准字H20033877 | 4.0g | Category A | XJ01XXL096B001040102954 | NHSA |
| Ha Yao Group Pharmaceutical Factory romanized | 国药准字H20043046 | See source | Category A | XJ01XXL096B001040103712 | NHSA |
| Hunan Ke Lun Pharmaceutical Co., Ltd. romanized | 国药准字H43020771 | See source | Category A | XJ01XXL096B001040105006 | NHSA |
| Xiamen Bao Rui Pharma Co., Ltd. romanized | 国药准字H20247324 | See source | Category A | XJ01XXL096B001040200322 | NHSA |
| Shanghai Shang Yao Xin Ya Pharma Co., Ltd. romanized | 国药准字H20023345 | See source | Category A | XJ01XXL096B001040200796 | NHSA |
| Ha Yao Group Pharmaceutical Factory romanized | 国药准字H20043047 | See source | Category A | XJ01XXL096B001040203712 | NHSA |
| Xiamen Bao Rui Pharma Co., Ltd. romanized | 国药准字H20247323 | See source | Category A | XJ01XXL096B001050100322 | NHSA |
| Shanxi Shuang Yan Pharma Co., Ltd. romanized | 国药准字H20033877 | 4.0g | Category A | XJ01XXL096B001050102954 | NHSA |
| Xiamen Bao Rui Pharma Co., Ltd. romanized | 国药准字H20247323 | See source | Category A | XJ01XXL096B001050200322 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054161 | See source | Category A | XJ01XXL096B013010104152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054161 | See source | Category A | XJ01XXL096B013010204152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054161 | See source | Category A | XJ01XXL096B013010304152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054161 | See source | Category A | XJ01XXL096B013010404152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054162 | See source | Category A | XJ01XXL096B013020104152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054162 | See source | Category A | XJ01XXL096B013020204152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054162 | See source | Category A | XJ01XXL096B013020304152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054162 | See source | Category A | XJ01XXL096B013020404152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054163 | See source | Category A | XJ01XXL096B013030104152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054163 | See source | Category A | XJ01XXL096B013030204152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054163 | See source | Category A | XJ01XXL096B013030304152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20054163 | See source | Category A | XJ01XXL096B013030404152 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Loaded records: 16 filings and 6 distinct first applicants.
Supplement 9 · Generic 7
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | CYHB2650021 | Supplement | 2026/01/23 | Not stated by source | CDE |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | CYHB2650020 | Supplement | 2026/01/23 | Not stated by source | CDE |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | CYHB2650019 | Supplement | 2026/01/23 | Not stated by source | CDE |
| Hainan Tong Yong San Yang Pharma Co., Ltd. romanized | CYHB2650018 | Supplement | 2026/01/23 | Not stated by source | CDE |
| Hubei Min Kang Pharmaceutical Co., Ltd. romanized; Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | CYHB2650168 | Supplement | 2026/08/07 | Not stated by source | CDE |
| Hubei Min Kang Pharmaceutical Co., Ltd. romanized; Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | CYHB2650167 | Supplement | 2026/08/07 | Not stated by source | CDE |
| Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CYHB2650116 | Supplement | 2026/05/13 | Not stated by source | CDE |
| Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CYHB2650115 | Supplement | 2026/05/13 | Not stated by source | CDE |
| Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CYHB2650114 | Supplement | 2026/05/13 | Not stated by source | CDE |
| Hebei Jiu Hui Pharmaceuticals Zhi Zao Co., Ltd. romanized; Shenzhen Shi Hai Bin Pharmaceutical Co., Ltd. romanized | CYHS2503789 | Generic | 2025/10/24 | Not stated by source | CDE |
| Hebei Jiu Hui Pharmaceuticals Zhi Zao Co., Ltd. romanized; Shenzhen Shi Hai Bin Pharmaceutical Co., Ltd. romanized | CYHS2503788 | Generic | 2025/10/24 | Not stated by source | CDE |
| Beijing Pin Shang Pin Pharmaceuticals Technology Co., Ltd. romanized; Shanxi Pu De Pharma Co., Ltd. romanized | CYHS2503267 | Generic | 2025/09/05 | Not stated by source | CDE |
| Beijing Pin Shang Pin Pharmaceuticals Technology Co., Ltd. romanized; Shanxi Pu De Pharma Co., Ltd. romanized | CYHS2503265 | Generic | 2025/09/05 | Not stated by source | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CYHS2602780 | Generic | 2026/11/11 | Not stated by source | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CYHS2602779 | Generic | 2026/11/11 | Not stated by source | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CYHS2602778 | Generic | 2026/11/11 | Not stated by source | CDE |
Loaded records: 6 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | CYHS2601484 | Generic | 2026/06/24 | Not stated by source | CDE |
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | CYHS2601483 | Generic | 2026/06/24 | Not stated by source | CDE |
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | CYHS2601481 | Generic | 2026/06/24 | Not stated by source | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CYHS2602780 | Generic | 2026/11/11 | Not stated by source | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CYHS2602779 | Generic | 2026/11/11 | Not stated by source | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CYHS2602778 | Generic | 2026/11/11 | Not stated by source | CDE |
Non-component matches: 9 companies with A status and 5 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 磷霉素钠 · No verified English name | Rui Yang Pharmaceutical Co., Ltd. romanized | Y20250001344 | I | Exact ingredient | 2026/06/04 | CDE |
| 磷霉素钙 · No verified English name | Anhui Ding Wang Pharmaceuticals Co., Ltd. romanized | Y20260000427 | I | Salt-normalized ingredient | 2026/06/01 | CDE |
| 磷霉素钠 · No verified English name | Jing Jing Pharma Co., Ltd. romanized | Y20260000146 | I | Exact ingredient | 2026/03/16 | CDE |
| 磷霉素钠 · No verified English name | Fu An Pharma Group Chongqing Bo Sheng Pharmaceutical Co., Ltd. romanized | Y20250001120 | I | Exact ingredient | 2025/11/25 | CDE |
| 磷霉素钠 · No verified English name | Zhejiang Bai Yun Shan Ang Li Kang Pharmaceutical Co., Ltd. romanized | Y20250000589 | I | Exact ingredient | 2025/06/27 | CDE |
| 磷霉素钙 · No verified English name | Chi Feng Ai Ke Pharmaceutical Technology Co., Ltd. romanized | Y20240000818 | A | Salt-normalized ingredient | 2026/01/30 | CDE |
| 磷霉素钠 · No verified English name | ERCROS, S.A. | Y20230000979 | A | Exact ingredient | 2024/12/25 | CDE |
| 磷霉素氨丁三醇 · No verified English name | Hunan Hua Na Da Pharmaceutical Factory Shou Xing Drug Co., Ltd. romanized | Y20190008939 | A | Salt-normalized ingredient | 2024/01/30 | CDE |
| 磷霉素钙 · No verified English name | Shanxi Dong Jin Pharmaceutical Co., Ltd. romanized | Y20190005637 | A | Salt-normalized ingredient | — | CDE |
| 磷霉素钠 · No verified English name | Shanxi Dong Jin Pharmaceutical Co., Ltd. romanized | Y20190005636 | A | Exact ingredient | — | CDE |
| 磷霉素氨丁三醇 · No verified English name | Gui Lin Hua Xin Pharmaceutical Co., Ltd. romanized | Y20190005284 | A | Salt-normalized ingredient | 2024/09/21 | CDE |
| 磷霉素钠 · No verified English name | Shanghai Shang Yao Xin Ya Pharma Co., Ltd. romanized | Y20190005149 | A | Exact ingredient | — | CDE |
| 磷霉素钙 · No verified English name | Shanghai Shang Yao Xin Ya Pharma Co., Ltd. romanized | Y20190005146 | A | Salt-normalized ingredient | — | CDE |
| 磷霉素钠 · No verified English name | Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | Y20190004363 | A | Exact ingredient | 2025/07/12 | CDE |
| 磷霉素氨丁三醇 · No verified English name | Dong Bei Pharmaceutical Group Co., Ltd. romanized | Y20190003126 | A | Salt-normalized ingredient | 2024/04/24 | CDE |
| 磷霉素钙 · No verified English name | Dong Bei Pharmaceutical Group Co., Ltd. romanized | Y20190003103 | A | Salt-normalized ingredient | 2024/04/24 | CDE |
| 磷霉素钠 · No verified English name | Dong Bei Pharmaceutical Group Co., Ltd. romanized | Y20190003101 | A | Exact ingredient | 2024/04/24 | CDE |
| 磷霉素钠 · No verified English name | Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | Y20190002881 | A | Exact ingredient | — | CDE |
| 磷霉素钙 · No verified English name | Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | Y20190002878 | A | Salt-normalized ingredient | — | CDE |
| 磷霉素氨丁三醇 · No verified English name | Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | Y20190002877 | A | Salt-normalized ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/16 06:35. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
CYHS2602780
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗CYHS2602779
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗CYHS2602778
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗CYHS2503131
Fact date: 2026/11/09 (Publication date) · Publication date: 2026/11/09 · Site observation date: 2026/11/09
Notification delivered; the specific outcome remains to be checked.
View source · Table row 6 ↗CYHS2503130
Fact date: 2026/11/09 (Publication date) · Publication date: 2026/11/09 · Site observation date: 2026/11/09
Notification delivered; the specific outcome remains to be checked.
View source · Table row 5 ↗CYHS2601484
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2026/06/24
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗CYHS2601483
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2026/06/24
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗CYHS2601481
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2026/06/24
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
First index-page publication dates: 2026-10-29 to 2026-11-13; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 11/30; discovered pending details: 9. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
US$200
Billed every month
Sign in to subscribeUS$540
Billed every three months
US$180 per month
Sign in to subscribeUS$1,920
Billed every year
US$160 per month
Sign in to subscribeSeparate one-time purchase
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy
No account needed.
Covers all drugs in the loaded CDE records, not only this one: weekly acceptance counts, top-10 lists and definitions. View the latest report